Bone marrow damage represents a significant problem in cancer treatment. Therefore, it is clear that the pharmacologic protection against bone marrow damage is of considerable interest, since the development of novel and effective medical approaches to combat radiation or cytotoxic damage are of major importance not only to the medical field but also to several industries and the military. This review represents a summary of our knowledge of the effects of various glucans on bone marrow protection.

Institute of Microbiology Czech Academy of Sciences Prague Czech Republic ; 2 University of Louisville Department of Pathology Louisville KY USA

Zobrazit více v PubMed

Novak M.Vetvicka V. β-glucans, history, and the present: immunomodulatory aspects and mechanisms of action. J Immunotoxicol 2008;5:47-57. PubMed

Smelcerovic A, Knezevic-Jugovic Z, Petronijevic Z.Microbial polysaccharides and their derivatives as current and prospective pharmaceuticals. Curr Pharm Des 2008;14:3168-95. PubMed

Vetvicka V. eds. β-Glucans as Natural Biological Response Modifiers. New York: Nova Science Publ., 2013.

Hong F, Yan J, Baran JT, et al. Mechanism by which orally administered β-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. J Immunol 2004;173:797-806. PubMed

Vetvicka V, Dvorak B, Vetvickova J, et al. Orally administered marine (1-->3)-beta-D-glucan Phycarine stimulates both humoral and cellular immunity. Int J Biol Macromol 2007;40:291-8. PubMed

Nanba H, Kuroda H.Antitumor mechanisms of orally administered shiitake fruit bodies. Chem Pharm Bull (Tokyo) 1987;35:2459-64. PubMed

Suzuki I, Sakurai T, Hashimoto K, et al. Inhibition of experimental pulmonary metastasis of Lewis lung carcinoma by orally administered beta-glucan in mice. Chem Pharm Bull (Tokyo) 1991;39:1606-8. PubMed

Cheung NK, Modak S. Oral (1-->3),(1-->4)-beta-D-glucan synergizes with antiganglioside GD2 monoclonal antibody 3F8 in the therapy of neuroblastoma. Clin Cancer Res 2002;8:1217-23. PubMed

Cheung NK, Modak S, Vickers A, et al. Orally administered beta-glucans enhance anti-tumor effects of monoclonal antibodies. Cancer Immunol Immunother 2002;51:557-64. PubMed PMC

Vetvicka V, Thornton BP, Wieman TJ, et al. Targeting of natural killer cells to mammary carcinoma via naturally occurring tumor cell-bound iC3b and beta-glucan-primed CR3 (CD11b/CD18). J Immunol 1997;159:599-605. PubMed

Yan J, Vetvicka V, Xia Y, et al. β-Glucan, a “specific” biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18). J Immunol 1999;163:3045-52. PubMed

Vetvicka V, Vetvickova J.β-1,3-Glucan: silver bullet or hot air? Open Glycosci 2010;3:1-6

Burgaleta C, Golde DW. Effect of glucan on granulopoiesis and macrophage genesis in mice. Cancer Res 1977;37:1739-42. PubMed

Patchen ML, Mac Vittie TJ. Use of glucan to enhance hemopoietic recovery after exposure to cobalt-60 irradiation. Adv Exp Med Biol 1982;155:267-72. PubMed

Wagnerová J, Lísková A, Navarová J, et al. The effect of two glucan carboxymethyl derivatives with various substitution degrees on cyclophosphamide immunosuppression in mice. Immunopharmacol Immunotoxicol 1993;15:227-42. PubMed

Fabrikant J. eds. Radiobiology. Chicago: Year Book Medical, 1972.

Zirkle RE. eds. Biological Effects of External X and Gamma Radiation. National Nuclear Energy Series. New York: McGraw-Hill Book Company, 1954.

Kennedy JC, Till JE, Siminovitch L. Radiosensitivity of the immune response to sheep red blood cells in the mouse as measured by the hemolytic plaque method. J Immunol 1965;94:715-22. PubMed

Kwan DK, Norman A. Radiosensitivity of human lymphocytes and thymocytes. Radiat Res 1977;69:143-51. PubMed

Hammond CW, Tompkins M, Miller CP. Studies on susceptibility to infection following ionizing radiation. J Exp Med 1954;99:405-10. PubMed PMC

Talmage DW. Effect of ionizing radiation on resistance to infection. Annu Rev Microbiol 1955;9:335-46. PubMed

Smith WW, Alderman IM, Gillespie RE. Hemopoietic recovery induced by bacterial endotoxin in irradiated mice. Am J Physiol 1958;192:549-56. PubMed

Gordon MY, Aguado M, Blackett NM. Effects of BCG and Corynebacterium parvum on the haemopoietic precursor cells in continuously irradiated mice: possible mechanisms of action in immunotherapy. Eur J Cancer 1977;13:229-33. PubMed

Dimitrov NV, Andre S, Eliopoulos G, et al. Effect of corynebacterium parvum on bone marrow cell cultures (38557). Proc Soc Exp Biol Med 1975;148:440-2. PubMed

Wolmark N, Fisher B.The effect of a single and repeated administration of Corynebacterium parvum on bone marrow macrophage colony production in syngeneic tumor-bearing mice. Cancer Res 1974;34:2869-72. PubMed

Fisher B, Taylor S, Levine M, et al. Effect of Mycobacterium bowis (Strain Bacillus Calmette-Guérin) on macrophage production by the bone marrow of tumor-bearing mice. Cancer Res 1974;34:1668-70. PubMed

Pilemer L, Ecker EE. Anticomplementary factor in fresh yeast. J Biol Chem 1941;137:139-42

Fitzpatrick FW, Haynes LJ, Silver NJ, et al. Effect of glucan derivatives upon phagocytosis by mice. J Reticuloendothel Soc 1964;1:423-8. PubMed

Peschle C, Marone G, Genovese A, et al. Increased erythropoietin production in anephric rats with hyperplasia of the reticuloendothelial system induced by colloidal carbon or zymosan. Blood 1976;47:325-37. PubMed

Di Luzio NR. Immunopharmacology of glucan: a broad spectrum enhancer of host defense mechanisms. Trends Pharmacol Sci 1983;4:344-7

Di Luzio NR. Update on the immunomodulating activities of glucan. Springer Semin Immunopathol 1985;8:387-400. PubMed

Williams DL, DiLuzio NR. Glucan-induced modification of murine viral-hepatitis. Science 1980;208:67-9. PubMed

Kokoshis PL, Williams DL, Cook JA, et al. Increased resistance to Staphylococcus aureus infection and enhancement in serum lysozyme activity by glucan. Science 1978;199:1340-2. PubMed

Di Luzio NR, Williams DL. Protective effect of glucan against systemic Staphylococcus aureus septicemia in normal and leukemic mice. Infect Immun 1978;20:804-10. PubMed PMC

Williams DL, Cook JA, Hoffmann EO, et al. Protective effects of glucan in experimentally induced candidiasis. J Reticuloendothel Soc 1978;23:479-90. PubMed

Browder IW, Williams DL, Kitahama A, et al. Modification of postoperative C-albicans sepsis by glucan immunostimulation. Int J Immunopharmacol 1984;6:19-26. PubMed

Williams DL, Mueller A, Browder W. Glucan-based macrophage stimulators: a review of their anti-infective potential. Clin Immunother 1996;5:392-9

Brown GD, Gordon S. Fungal β-glucans and mammalian immunity. Immunity 2003;19:311-5. PubMed

Akramienė D, Kondrotas A, Didžiapetrienė J, et al. Effects of β- glucans on the immune system. Medicina (Kaunas) 2007;43:597-606. PubMed

Burgaleta C, Golde DW. Effect of glucan on granulopoiesis and macrophage genesis in mice. Cancer Res 1977;37:1739-42. PubMed

Niskanen EO, Burgaleta C, Cline MJ, et al. Effect of glucan, a macrophage activator, on murine hemopoietic cell proliferation in diffusion chambers in mice. Cancer Res 1978;38:1406-9. PubMed

Patchen ML, Lotzová E. Modulation of murine hemopoiesis by glucan. Exp Hematol 1980;8:409-22. PubMed

Patchen ML, MacVittie TJ. Dose-dependent responses of murine pluripotent stem cells and myeloid and erythroid progenitor cells following administration of the immunomodulating agent glucan. Immunopharmacology 1983;5:303-13. PubMed

Patchen ML, MacVittie TJ. Temporal response of murine pluripotent stem cells and myeloid and erythroid progenitor cells to low-dose glucan treatment. Acta Haematol 1983;70:281-8. PubMed

Patchen ML, MacVittie TJ. Hemopoietic effects of intravenous soluble glucan administration. J Immunopharmacol 1986;8:407-25. PubMed

Patchen ML, DiLuzio NR, Jacques P, et al. Soluble polyglycans enhance recovery from cobalt-60--induced hemopoietic injury. J Biol Response Mod 1984;3:627-33. PubMed

Patchen ML, Vaudrain T, Correira H, et al. In vitro and in vivo hematopoietic activities of Betafectin PGG-glucan. Exp Hematol 1998;26:1247-54. PubMed

Pospísil M, Jarý J, Netíková J, et al. Glucan-induced enhancement of hemopoietic recovery in gamma-irradiated mice. Experientia 1982;38:1232-4. PubMed

Pospísil M, Sandula J, Pipalová I, et al. Hemopoiesis stimulating and radioprotective effects of carboxymethylglucan. Physiol Res 1991;40:377-80. PubMed

Hofer M, Pospíšil M, Viklická Š, et al. Effects of postirradiation carboxymethylglucan administration in mice. Int J Immunopharmacol 1995;17:167-74. PubMed

Hofer M, Pospísil M, Pipalová I, et al. Haemopoiesis-enhancing effects of repeatedly administered carboxymethylglucan in mice exposed to fractionated irradiation. Folia Biol (Praha) 1995;41:249-56. PubMed

Hofer M, Pospíšil M.Glucan as stimulator of hemopoiesis in normal and gamma-irradiated mice. A survey of the authors’ results. Int J Immunopharmacol 1997;19:607-9. PubMed

Hofer M, Pospíšil M.Modulation of animal and human hemopoiesis by β-glucans: a review. Molecules 2011;16:7969-79. PubMed PMC

Patchen ML, Brook I, Elliott TB, et al. Adverse effects of pefloxacin in irradiated C3H/HeN mice: correction with glucan therapy. Antimicrob Agents Chemother 1993;37:1882-9. PubMed PMC

Patchen ML, D’Alesandro MM, Chirigos MA, et al. Radioprotection by biological response modifiers alone and in combination with WR-2721. Pharmacol Ther 1988;39:247-54. PubMed

Patchen ML, MacVittie TJ, Weiss JF. Combined modality radioprotection: the use of glucan and selenium with WR-2721. Int J Radiat Oncol Biol Phys 1990;18:1069-75. PubMed

Pospísil M, Netíková J, Pipalová I, et al. Combined radioprotection by preirradiation peroral cystamine and postirradiation glucan administration. Folia Biol (Praha) 1991;37:117-24. PubMed

Baker WH, Nold JB, Patchen ML, et al. Histopathologic effects of soluble glucan and WR-2721, independently and combined in C3H/HeN mice. Proc Soc Exp Biol Med 1992;201:180-91. PubMed

Pospísil M, Hofer M, Pipalová I, et al. Enhancement of hematopoietic recovery in gamma-irradiated mice by the joint use of diclofenac, an inhibitor of prostaglandin production, and glucan, a macrophage activator. Exp Hematol 1992;20:891-5. PubMed

Hofer M, Pospíšil M, Viklická Š, et al. Hemopoietic recovery in repeatedly irradiated mice can be enhanced by a repeatedly administered combination of diclofenac and glucan. J Leukoc Biol 1993;53:185-9. PubMed

Turnbull JL, Patchen ML, Scadden DT. The poly-saccharide, PGG-glucan, enhances human myelopoiesis by direct action independent of and additive to early-acting cytokines. Acta Haematol 1999;102:66-71. PubMed

Jin M, Jeon H, Jung HJ, et al. Enhancement of repopulation and hematopoiesis of bone marrow cells in irradiated mice by oral administration of PG101, a water-soluble extract from Lentinus lepideus. Exp Biol Med (Maywood) 2003;228:759-66. PubMed

Jin M, Jung HJ, Choi JJ, et al. Activation of selective transcription factors and cytokines by water-soluble extract from Lentinus lepideus. Exp Biol Med (Maywood) 2003;228:749-58. PubMed

Cramer DE, Allendorf DJ, Baran JT, et al. Beta-glucan enhances complement-mediated hemopoietic recovery after bone marrow injury. Blood 2006;107:835-40. PubMed PMC

Oliveira RJ, Ribeiro LR, da Silva AF, et al. Evaluation of antimutagenic activity and mechanisms of action of beta-glucan from barley, in CHO-k1 and HTC cell lines using the micronucleus test. Toxicol In Vitro 2006;20:1225-33. PubMed

Oliveira RJ, Matuo R, da Silva AF, et al. Protective effect of beta-glucan extracted from Saccharomyces cerevisiae, against DNA damage and cytotoxicity in wild-type (k1) and repair-deficient (xrs5) CHO cells. Toxicol In Vitro 2007;21:41-52. PubMed

Lin H, She YH, Cassileth BR, et al. Maitake beta-glucan MD-fraction enhances bone marrow colony formation and reduces doxorubicin toxicity in vitro. Int Immunopharmacol 2004;4:91-9. PubMed

Tohamy AA, El-Ghor AA, El-Nahas SM, et al. Beta-glucan inhibits the genotoxicity of cyclophosphamide, adriamycin and cisplatin. Mutat Res 2003;541:45-53. PubMed

Chorvatovicová D, Machová E, Sandula J.Effect of ultrasonicated carboxymethylglucan on cyclophosphamide induced mutagenicity. Mutat Res 1996;371:115-20. PubMed

Chorvatovicová D, Machová E, Sandula J.Ultrasonication: the way to achieve antimutagenic effect of carboxymethyl-chitin-glucan by oral administration. Mutat Res 1998;412:83-9. PubMed

Oliveira RJ, Salles MJ, da Silva AF, et al. Effects of the polysaccharide beta-glucan on clastogenicity and teratogenicity caused by acute exposure to cyclophosphamide in mice. Regul Toxicol Pharmacol 2009;53:164-73. PubMed

Oliveira RJ, Salles MJ, da Silva AF, et al. In vivo evaluation of the antimutagenic and antigenotoxic effects of β-glucan extracted from Saccharomyces cerevisiae in acute treatment with multiple doses. Genet Mol Biol 2013;36:413-24. PubMed PMC